Corpus Intelligence IC Memo — ACADIA GENERAL HOSPITAL 2026-04-26 12:35 UTC
IC Memo — ACADIA GENERAL HOSPITAL
Investment Committee Memorandum | LA | 54 beds | Grade C | EBITDA uplift $3.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ACADIA GENERAL HOSPITAL

CCN 190044 | nan, LA | 54 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ACADIA GENERAL HOSPITAL is a 54-bed under-performing / distressed in nan, LA with $40.2M in net patient revenue and a -25.1% operating margin. The hospital serves a payer mix of 43.6% Medicare, 1.4% Medicaid, and 54.9% commercial.

Thesis: Turnaround. Our ML models identify $3.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -25.1% to -17.8% (+736bps).

Net Revenue HCRIS$40.2M
Current EBITDA COMPUTED$-10.1M
Operating Margin COMPUTED-25.1%
Occupancy HCRIS36.5%
Revenue / Bed COMPUTED$745K
Net-to-Gross HCRIS18.9%
Distress Probability ML50.6%

2. Market Context & Competitive Position

212
LA Hospitals
-3.5%
State Median Margin
88
Comparable Hospitals

LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -25.1% places it below the state median. Among 88 size-comparable peers (27-108 beds), the median margin is -2.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (27-108), prioritizing same-state peers. 88 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ACADIA GENERAL HOSPITAL (Target)LA54$40.2M-25.1%
ST. PATRICK HOSPITALLA100$189.4M-7.4%
UNIVERSITY HOSPITAL & CLINICSLA52$158.9M-33.4%
SOUTHERN REGIONAL MEDICAL CORPLA64$97.3M-50.0%
OCHSNER LSU HEALTH MONROELA84$85.1M-50.0%
NATCHITOCHES REGIONAL MEDICAL LA81$82.4M-21.8%
LAKE AREA MEDICAL CENTERLA88$81.6M2.2%
NEW ORLEANS EAST HOSPITALLA60$77.6M-29.7%
OUR LADY OF THE ANGELS HOSPITALA36$76.2M-4.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$844K+210bp18mo
Cost to Collect4.5%2.5%$804K+200bp12mo
Denial Rate Reduction12.0%6.5%$796K+198bp12mo
A/R Days Reduction5200.0%3800.0%$489K+122bp9mo
Clean Claim Rate88.0%96.0%$26K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$844K
Cost to Collect
$804K
Denial Rate Reduction
$796K
A/R Days Reduction
$489K
Clean Claim Rate
$26K
Total EBITDA Uplift$3.0M
Current EBITDA$-10.1M
+ RCM Uplift+$3.0M
Pro Forma EBITDA$-7.1M
Current Margin-25.1%
Pro Forma Margin-17.8%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-15.5M$-37.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-15.5M$-45.8M0.00x-100.0%
Bull Case9.0x11.0x$-14.0M$-41.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-14.0M$-48.9M0.00x-100.0%
Bear Case11.0x10.0x$-17.1M$-46.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-17.1M$-57.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 50.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 88 hospitals with 27-108 beds
  • Same-state prioritization (n=89)
  • Comp margins: P25=-22.6% / P50=-2.9% / P75=4.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.